BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 32368053)

  • 1. Transferrin Conjugated pH- and Redox-Responsive Poly(Amidoamine) Dendrimer Conjugate as an Efficient Drug Delivery Carrier for Cancer Therapy.
    Hu Q; Wang Y; Xu L; Chen D; Cheng L
    Int J Nanomedicine; 2020; 15():2751-2764. PubMed ID: 32368053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cRGD mediated redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for efficiently intracellular antitumor drug delivery.
    Wang Y; Hu W; Ding B; Chen D; Cheng L
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111195. PubMed ID: 32619785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
    Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
    Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
    Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
    ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated Dendrimer-Doxorubicin Cojugates as pH-Sensitive Drug Delivery Systems: Synthesis and In Vitro Characterization.
    She W; Pan D; Luo K; He B; Cheng G; Zhang C; Gu Z
    J Biomed Nanotechnol; 2015 Jun; 11(6):964-78. PubMed ID: 26353586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ethylene glycol) versus dendrimer prodrug conjugates: influence of prodrug architecture in cellular uptake and transferrin mediated targeting.
    Aher N; Banerjee S; Bhansali S; Yadav R; Shidore M; Mhaske S; Chaudhari R; Asai S; Jalota-Badhwar A; Khandare J
    J Biomed Nanotechnol; 2013 May; 9(5):776-89. PubMed ID: 23802407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells.
    Liu D; Hu H; Zhang J; Zhao X; Tang X; Chen D
    Chem Pharm Bull (Tokyo); 2011; 59(1):63-71. PubMed ID: 21212549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of a multifunctional gold-doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release.
    Khutale GV; Casey A
    Eur J Pharm Biopharm; 2017 Oct; 119():372-380. PubMed ID: 28736333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox and pH-responsive poly (amidoamine) dendrimer-poly (ethylene glycol) conjugates with disulfide linkages for efficient intracellular drug release.
    Hu W; Cheng L; Cheng L; Zheng M; Lei Q; Hu Z; Xu M; Qiu L; Chen D
    Colloids Surf B Biointerfaces; 2014 Nov; 123():254-63. PubMed ID: 25277289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
    Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
    Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.
    He H; Li Y; Jia XR; Du J; Ying X; Lu WL; Lou JN; Wei Y
    Biomaterials; 2011 Jan; 32(2):478-87. PubMed ID: 20934215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascade-Targeting of Charge-Reversal and Disulfide Bonds Shielding for Efficient DOX Delivery of Multistage Sensitive MSNs-COS-SS-CMC.
    Cui L; Liu W; Liu H; Qin Q; Wu S; He S; Zhang Z; Pang X; Zhu C
    Int J Nanomedicine; 2020; 15():6153-6165. PubMed ID: 32884269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
    Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
    Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
    Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.